BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26637888)

  • 1. Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study.
    Tempfer CB; Rezniczek GA; Ende P; Solass W; Reymond MA
    Anticancer Res; 2015 Dec; 35(12):6723-9. PubMed ID: 26637888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study.
    Tempfer CB; Winnekendonk G; Solass W; Horvat R; Giger-Pabst U; Zieren J; Rezniczek GA; Reymond MA
    Gynecol Oncol; 2015 May; 137(2):223-8. PubMed ID: 25701703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis.
    Tempfer CB; Giger-Pabst U; Seebacher V; Petersen M; Dogan A; Rezniczek GA
    Gynecol Oncol; 2018 Jul; 150(1):23-30. PubMed ID: 29743140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience.
    Tempfer CB; Celik I; Solass W; Buerkle B; Pabst UG; Zieren J; Strumberg D; Reymond MA
    Gynecol Oncol; 2014 Feb; 132(2):307-11. PubMed ID: 24275155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
    Odendahl K; Solass W; Demtröder C; Giger-Pabst U; Zieren J; Tempfer C; Reymond MA
    Eur J Surg Oncol; 2015 Oct; 41(10):1379-85. PubMed ID: 26138283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Clinical Data of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) as Salvage Therapy for Peritoneal Metastatic Biliary Tract Cancer.
    Falkenstein TA; Götze TO; Ouaissi M; Tempfer CB; Giger-Pabst U; Demtröder C
    Anticancer Res; 2018 Jan; 38(1):373-378. PubMed ID: 29277797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal cisplatin and doxorubicin as maintenance chemotherapy for unresectable ovarian cancer: a case report.
    Tempfer CB; Hartmann F; Hilal Z; Rezniczek GA
    BMC Cancer; 2017 Jan; 17(1):26. PubMed ID: 28061769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis.
    Nadiradze G; Giger-Pabst U; Zieren J; Strumberg D; Solass W; Reymond MA
    J Gastrointest Surg; 2016 Feb; 20(2):367-73. PubMed ID: 26511950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose pressurized intraperitoneal aerosol chemotherapy (PIPAC) as an alternative therapy for ovarian cancer in an octogenarian patient.
    Giger-Pabst U; Solass W; Buerkle B; Reymond MA; Tempfer CB
    Anticancer Res; 2015 Apr; 35(4):2309-14. PubMed ID: 25862894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
    Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
    Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
    Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressurized Intraperitoneal Aerosol Chemotherapy, a Palliative Treatment Approach for Patients With Peritoneal Carcinomatosis: Description of Method and Systematic Review of Literature.
    Winkler CS; Sandhu J; Pettke E; Merchea A; Fong Y; Kumara HMCS; Whelan RL
    Dis Colon Rectum; 2020 Feb; 63(2):242-255. PubMed ID: 31914116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis.
    Larbre V; Alyami M; Mercier F; Vantard N; Bonnefoy I; Opsomer MA; Villeneuve L; Bakrin N; Rioufol C; Glehen O; Kepenekian V
    Anticancer Res; 2018 Dec; 38(12):6869-6875. PubMed ID: 30504403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study.
    Struller F; Horvath P; Solass W; Weinreich FJ; Strumberg D; Kokkalis MK; Fischer I; Meisner C; Königsrainer A; Reymond MA
    Ther Adv Med Oncol; 2019; 11():1758835919846402. PubMed ID: 31205501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
    Nowacki M; Alyami M; Villeneuve L; Mercier F; Hubner M; Willaert W; Ceelen W; Reymond M; Pezet D; Arvieux C; Khomyakov V; Lay L; Gianni S; Zegarski W; Bakrin N; Glehen O
    Eur J Surg Oncol; 2018 Jul; 44(7):991-996. PubMed ID: 29526367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis.
    Alyami M; Gagniere J; Sgarbura O; Cabelguenne D; Villeneuve L; Pezet D; Quenet F; Glehen O; Bakrin N; Passot G
    Eur J Surg Oncol; 2017 Nov; 43(11):2178-2183. PubMed ID: 28964609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressurized intra-peritoneal aerosol chemotherapy (PIPAC): increased intraperitoneal pressure does not affect distribution patterns but leads to deeper penetration depth of doxorubicin in a sheep model.
    Mimouni M; Richard C; Adenot P; Letheule M; Tarrade A; Sandra O; Dahirel M; Lilin T; Lecuelle B; Gélin V; Cohen J; Fauconnier A; Vialard F; Huchon C; Chavatte-Palmer P
    BMC Cancer; 2021 Apr; 21(1):461. PubMed ID: 33902518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.